UCB Archives - Spinal Surgery News

24 March 2015

Romosozumab: Bone-forming agent promising for osteoporosis patients

Romosozumab, A new bone-forming agent currently under study by Amgen Inc. and Belgium’s UCB, has shown promise in research into...

and receive all of the latest news via our weekly newsletter

"*" indicates required fields

About Us

Spinal Surgery News online features news, opinions, events, reviews, product information and a wide range of peer-reviewed scientific material of interest to specialist spinal professionals.

The journal has several eminent editorial contributors guiding its content; and we also work closely with companies in the industry to ensure it remains useful and relevant.

UCB

Romosozumab: Bone-forming agent promising for osteoporosis patients

Surgeon warns widening gender gap threatens hard-won gains for women in surgery

Scoliosis Research Society announces a new collaborative with EUROSPINE

Surgeon in Focus with Dr Peter Derman

Next-gen spinal implants company appoints new CEO ahead of US expansion

Spinal cord stimulation may help prevent excess mortality associated with chronic pain

Three critical advances in spine care over the past 25 years affecting aging populations

About Us

UCB

Romosozumab: Bone-forming agent promising for osteoporosis patients

and receive all of the latest news via our weekly newsletter

Surgeon warns widening gender gap threatens hard-won gains for women in surgery

Scoliosis Research Society announces a new collaborative with EUROSPINE

Surgeon in Focus with Dr Peter Derman

Next-gen spinal implants company appoints new CEO ahead of US expansion

Spinal cord stimulation may help prevent excess mortality associated with chronic pain

Three critical advances in spine care over the past 25 years affecting aging populations

About Us

Subscribe

and receive all of the latest news via our weekly newsletter